EVISA Glossary on | Contact EVISA | Sitemap | Home   
 Advanced search
The establishment of EVISA is funded by the EU through the Fifth Framework Programme (G7RT- CT- 2002- 05112).


Supporters of EVISA includes:



Biopharmaceutics and Drug Disposition


 

Status
active
Subject

Source type
Journal
Publisher
ISBN ISSN
0142-2782
E ISSN
1099-081X
First volume
1
Last volume
31+
Homepage
Description

Biopharmaceutics & Drug Disposition publishes original review articles, short communications, and reports in biopharmaceutics, drug disposition, pharmacokinetics and pharmacodynamics, especially those that have a direct relation to the drug discovery/development and the therapeutic use of drugs. These include:

  • animal and human pharmacological studies that focus on therapeutic response. pharmacodynamics, and toxicity related to plasma and tissue concentrations of drugs and their metabolites,
  • in vitro and in vivo drug absorption, distribution, metabolism, transport, and excretion studies that facilitate investigations related to the use of drugs in man
  • studies on membrane transport and enzymes, including their regulation and the impact of pharmacogenomics on drug absorption and disposition,
  • simulation and modeling in drug discovery and development
  • theoretical treatises
  • includes themed issues and reviews
and exclude manuscripts on
  • bioavailability studies reporting only on simple PK parameters such as Cmax, tmax and t1/2 without mechanistic interpretation
  • analytical methods

Reports must contain current citation of the literature and convey new information.



Related links:









Imprint     Disclaimer

© 2003 - 2010 by European Virtual Institute for Speciation Analysis ( EVISA )